Understanding how Mx2 inhibits HIV-1 infection
Inhibition of lentiviral nuclear import pathways by Mx2
This study is looking at how a protein called Mx2 helps stop HIV-1 from getting into cells, which could lead to new treatments for people living with HIV.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11077811 on NIH RePORTER |
What this research studies
This research investigates the role of a protein called Mx2 in blocking the entry of HIV-1 into cells. By examining how Mx2 interacts with cellular pathways that transport viruses into the nucleus, the study aims to uncover the mechanisms that prevent HIV-1 from infecting non-dividing cells. The research will involve various cell types and conditions to understand the broader implications of Mx2's antiviral properties. Patients may benefit from insights that could lead to new antiviral therapies targeting HIV-1.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV-1 or those at high risk of HIV-1 infection.
Not a fit: Patients who are not infected with HIV-1 or those with other unrelated viral infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antiviral treatments for HIV-1 infection.
How similar studies have performed: Previous research has shown promising results in understanding antiviral mechanisms, suggesting that this approach may yield valuable insights.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Kane, Melissa E — University of Pittsburgh at Pittsburgh
- Study coordinator: Kane, Melissa E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.